Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage

Circulation

Volumn 108, Issue 1, 2003, Pages 104-109

  Hayakawa, Kenji ^c   Takemura, Genzou ^c   Kanoh, Motoo ^c   Li, Yiwen ^c   Koda, Masahiko ^c   Kawase, Yukinori ^c   Maruyama, Rumi ^c   Okada, Hideshi ^c   Minatoguchi, Shinya ^c   Fujiwara, Takako ^a   Fujiwara, Hisayoshi ^b  

^a KYOTO WOMEN'S UNIVERSITY   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

Apopstosis; Heart failure; Myocardial infarction; Remodeling

Indexed keywords

ACTIN; BENZYLOXYCARBONYLASPARTYL FLUOROMETHYLKETONE; CASPASE INHIBITOR; PANCASPASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL POPULATION; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; GRANULATION TISSUE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SCAR; SMOOTH MUSCLE; SURVIVAL RATE; ULTRASTRUCTURE;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CASPASES; CHRONIC DISEASE; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GRANULATION TISSUE; HEART; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; SURVIVAL RATE; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 0038502520     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000074225.62168.68     Document Type: Article

References (23)

1. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med. 1995;46:455-466.
2. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant. 2000;19:909-931.
3. McKay RG, Pfeffer MA, Pasternak RC, et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693-702.
4. Weisman HF, Bush DE, Mannisi JA, et al. Cellular mechanisms of myocardial infarct expansion. Circulation. 1988;78:186-201.
5. Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 1996;226:316-327.
6. Shan K, Kurrelmeyer K, Seta Y, et al. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol. 1997;12:218-223.
7. Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol. 1993;72:13G-21G.
8. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
9. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.
10. Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart disease -a novel therapeutic target? FASEB J. 2002;16:135-146.
11. Kanoh M, Takemura G, Misao J, et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation. 1999;99:2757-2764.
12. Elsässer A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol. 2000;32:711-724.
13. Knaapen MW, Davies MJ, De Bie M, et al. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res. 2001;51:304-312.
14. Hayakawa K, Takemura G, Koda M, et al. Sensitivity to apoptosis signal, clearance rate, and ultrastructure of fas ligand-induced apoptosis in in vivo adult cardiac cells. Circulation. 2002;105:3039-3045.
15. Takemura G, Ohno M, Hayakawa Y, et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res. 1998;82:1130-1138.
16. Deshmukh M, Vasilakos J, Deckwerth TL, et al. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J Cell Biol. 1996;135:1341-1345.
17. Baldi A, Abbate A, Bussani R, et al. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol. 2002;34:165-174.
18. Carr JG, Stevenson LW, Walden JA, et al. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1989;63:709-713.
19. Schürch W, Seemayer TA, Gabbiani G. In: Sternberg S, ed. Myofibroblast in Histology for Pathologists. New York, NY: Raven Press Publishers; 1992:109-144.
20. Yin FC. Ventricular wall stress. Circ Res. 1981;49:829-842.
21. Abbate A, Bussani R, Biondi-Zoccai GG, et al. Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction. Circulation. 2002;106:1051-1054.
22. Engler RL. Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion. Am J Cardiol. 1989;63:19E-23E.
23. Nagata S. Apoptosis by death factor. Cell. 1997;88:355-365.